1. Home
  2. NUAI vs VOGX Comparison

NUAI vs VOGX Comparison

Compare NUAI & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

N/A

Current Price

$4.73

Market Cap

403.6M

Sector

Energy

ML Signal

N/A

Logo Vogenx Inc Common Stock

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$17.81

Market Cap

482.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUAI
VOGX
Founded
N/A
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
403.6M
482.8M
IPO Year
2024
2026

Fundamental Metrics

Financial Performance
Metric
NUAI
VOGX
Price
$4.73
$17.81
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $11.67
N/A
AVG Volume (30 Days)
★ 7.9M
100.8K
Earning Date
11-12-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1.89
N/A
EPS
N/A
★ N/A
Revenue
★ $885,400.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,783.33
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 66.18
N/A
52 Week Low
$2.01
$14.56
52 Week High
$9.45
$38.41

Technical Indicators

Market Signals
Indicator
NUAI
VOGX
Relative Strength Index (RSI) 34.53 36.80
Support Level $3.89 N/A
Resistance Level $5.52 $36.96
Average True Range (ATR) 0.52 3.10
MACD -0.26 -1.08
Stochastic Oscillator 3.89 19.55

Price Performance

Historical Comparison
NUAI
VOGX

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: